The above results preliminarily suggested that the activation of NF-κB (p65) and ERK pathways promoted the invasion and migration ability of glioblastoma cells, while EP inhibited the activation of NF-κB (p65) and ERK and further inhibited the invasion and migration of glioblastoma cells. The gene discussed is NFKB1; the disease is glioblastoma.